Objective To investigate the diagnostic value of prostate-specific antigen isoform 2(p2PSA),prostate-specific antigen isoform 2 percentage(p2PSA%) and prostate health index(PHI) in the identification of benign and malignant prostate diseases.Methods A total of 250 male patients who underwent transrectal ultrasound-guided prostate biopsy were enrolled and classified into benign prostate disease group(145 cases) and prostate cancer group(105 cases) based on the pathological results,and they were classified into ≤65 years old and >65 years old groups according to ages. Total prostate-specific antigen(t-PSA),free prostate-specific antigen(f-PSA) and p2PSA were determined in serum samples from all the patients,and free prostate-specific antigen percentage(f-PSA%),p2PSA% and PHI were calculated. The efficiency of each index in the diagnosis of prostate cancer was evaluated by receiver operating characteristic(ROC) curve. Results Compared with benign prostate disease group,the t-PSA,p2PSA,p2PSA% and PHI of prostate cancer group were increased(P<0.01,P<0.001),and f-PSA% was decreased(P<0.001). There was no statistical significance in f-PSA between the 2 groups(P>0.05). ROC curve analysis results showed that,in ≤65 years old patients,the areas under curves(AUC) of t-PSA,f-PSA,f-PSA %,p2PSA,p2PSA% and PHI in the diagnosis of prostate cancer were 0.687,0.500,0.792,0.815,0.795 and 0.892,respectively. In >65 years old patients,the AUC of t-PSA,f-PSA,f-PSA %,p2PSA,p2PSA% and PHI in the diagnosis of prostate cancer were 0.748,0.542,0.900,0.780,0.843 and 0.929,respectively.Conclusions The diagnostic efficiency of prostate cancer markers differs in different ages. Prostate cancer markers,PHI,p2PSA and p2PSA%,can improve the differential diagnosis of benign and malignant prostate diseases.